Ruta Teterovska, Technical Sales Specialist at Cellexus International Ltd in United Kingdom will give an oral presentation at the 8th World Congress Targeting Therapy.
Presentation Title: CellMaker- The Ideal Solution for Scalable Phage Manufacturing
A few points of presentation:
As demand for GMP-compliant bacteriophage production grows, scalable and cost-effective upstream solutions are essential.
The CellMaker, a single-use airlift bioreactor, has proven to be an ideal system for phage amplification across 1.5–50L scale enabling transition from the R&D stages to GMP manufacturing. By eliminating mechanical stirring and relying solely on gas flow, it ensures efficient mixing, minimises shear stress, and enables rapid turnaround with high reproducibility. Depending on the gas used, the system supports both aerobic and anaerobic phage hosts.
Through ongoing collaborations—including a new partnership with Qeen Biotechnologies Inc—we aim to advance large-scale GMP manufacturing of therapeutic phages by enhancing production capabilities, automation, and future scale-up potential.
Targeting Phage Therapy 2025
June 10-11, 2025 – Berlin, Germany
